港股異動丨瑞聲科技跌近5% 遭多家大行唱空
格隆匯4月21日丨瑞聲科技(2018.HK)跌近5%,報36.7港元,總市值443.5億港元。大和下調瑞聲科技目標價,由45港元降至39港元,評級亦由“跑贏大市”下調至“持有”。匯豐研究本月發佈最新研報下調瑞聲股份目標價,由63.4港元降至51.2港元,評級維持“買入”,並下調集團今年至2022年各年盈利預測分別32%、0.1%及1%,以反映經營及研發成本提升。近日,光學產業龍頭大立光執行長林恩平在一次會議上對今年第二季度的市場需求做出預測稱:“由於今年一季度的營收規模下降,導致公司的毛利率也隨之下滑。另外包括舜宇光學、瑞聲科技等一線廠商也都表示,由於當前疫情持續蔓延,對於全球市場的影響仍不可控,公司業務可能因此遭到影響。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.